• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

AOS files Chapter 11, will continue to represent interests of ODs


The American Optometric Society (AOS) has filed for Chapter 11 bankruptcy and confirms it will continue to operate.


Los Angeles-The American Optometric Society (AOS) has confirmed that it will continue to operate as the professional optometric organization representing the individual optometrist.

Following the AOS vs. American Board of Optometry (ABO) lawsuit, the organization has received widespread encouragement from both members and non-members alike, according to the AOS.

In order to continue its mission, the AOS has chosen to seek protection under Chapter 11 of the U.S. Bankruptcy Code. The AOS will operate no differently, in principle, both in identifying significant issues in the profession and supporting organized optometry, at the state and national level.

The AOS will continue to mobilize a broad base of support to bring about positive change and prevent our profession from being damaged and divided.

Also, the AOS that will hold its 4th Annual CE Symposium April 12-14 at the Westin Riverwalk in San Antonio; the 3rd annual Harvey Yamamoto Student Scholarship will be awarded at that time. Early bird registration continues through Jan. 31.

Related Videos
Jacobi Cleaver, OD, FAAO
Jade Coats, OD, overviews a lecture on ocular pain and patient care
Jade Coats, OD, outlines two poster presentations she gave on a novel lipid-containing eye drop at the AOA Optometry's Meeting
Adam Alexander, OD, chats with Optometry Times about his AOA e-poster presentation on Miebo
Lorraine Provencher, MD, presenting slides
Megan Cavet, PhD
Nazlee Zebardast, MD, MSc, overviews her ARVO 2024 presentations on glaucoma and polygenic risk scores
© 2024 MJH Life Sciences

All rights reserved.